These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1140 related items for PubMed ID: 19578102
1. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study. Dhir V, Singh AP, Aggarwal A, Naik S, Misra R. Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102 [Abstract] [Full Text] [Related]
2. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [Abstract] [Full Text] [Related]
4. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Bruns A, Bläss S, Hausdorf G, Burmester GR, Hiepe F. Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891 [Abstract] [Full Text] [Related]
7. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics. Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT. J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730 [Abstract] [Full Text] [Related]
8. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052 [Abstract] [Full Text] [Related]
9. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus. Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M. Anticancer Res; 2001 Jan; 21(4B):3053-9. PubMed ID: 11712810 [Abstract] [Full Text] [Related]
10. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P. Scand J Rheumatol; 2007 Jan; 36(6):442-7. PubMed ID: 18092265 [Abstract] [Full Text] [Related]
11. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, Valet G, Lipsky PE, Dörner T. Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906 [Abstract] [Full Text] [Related]
12. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT. Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805 [Abstract] [Full Text] [Related]
13. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Liu C, Chen X, Jin Y, Qu R, Jiang PF, Wen GM, Tang ZH. Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664 [Abstract] [Full Text] [Related]
14. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y. Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [Abstract] [Full Text] [Related]
15. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphaël D, Ghillani P, Debre P, Piette JC, Gorochov G. Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999 [Abstract] [Full Text] [Related]
16. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Mellor-Pita S, Citores MJ, Castejon R, Yebra-Bango M, Tutor-Ureta P, Rosado S, Andreu JL, Vargas JA. Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277 [Abstract] [Full Text] [Related]
17. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E. Lupus; 2007 Jul; 16(7):489-96. PubMed ID: 17670847 [Abstract] [Full Text] [Related]
18. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M, Sugiura T, Katsumata Y, Fukasawa C, Ichida H, Higami S, Kamatani N. Arthritis Res Ther; 2006 Jul; 8(3):R62. PubMed ID: 16563187 [Abstract] [Full Text] [Related]
19. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease. Chen DY, Hsieh TY, Hsieh CW, Lin FJ, Lan JL. Arthritis Rheum; 2007 Dec 15; 57(8):1530-8. PubMed ID: 18050226 [Abstract] [Full Text] [Related]
20. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Scheinecker C, Zwölfer B, Köller M, Männer G, Smolen JS. Arthritis Rheum; 2001 Apr 15; 44(4):856-65. PubMed ID: 11315925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]